Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada ...Middle East

PR Newswire - News
Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene and betamethasone dipropionate) in Canada through Endo's subsidiary Paladin...

Read More Details
Finally We wish PressBee provided you with enough information of ( Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada )

Also on site :